Seeing a lot of criticism for Rabbit, Humane, and similar devices. Both publicly on Twitter and privately. The bull case for an AI-native "agent-ic" device, is that it deprecates app-based user interaction. "Links: Answers :: Apps: Actions". I differ from
@vkhosla
here in that the bottleneck is in hardware or fabrication facilities alone. We actually do not have good action models yet, well grounded in natural language. It is quite likely that GPT-4.5 or 5 can likely get to the sort of sweet spot there as GPT-3.5 got to, for chat and text. However, when that happens, the bottleneck won't be the hardware, because these models can never run on-device, for the foreseeable future (next 2-3 years). More algorithmic progress on how to get such capabilities in models that can run on-device is still an open question.

https://twitter.com/AravSrinivas/status/1745489529551905159

Toyota chairman: Engines still play role in going carbon-neutral

Akio Toyoda, chairman of Toyota Motor, revealed on Friday that the Japanese automaker has launched a project to develop a new internal combustion engine, saying, "We will continue producing engines because they still play a role as a practical means of achieving carbon neutrality," or net-zero emissions of carbon dioxide.

Read more here

I’m starting an incubator. Funded entirely by me. It’s called 8090.

Tell us what enterprise software you use and my team and I will build you an 80% feature complete version at a 90% discount.

We are using AI and offshoring to make this happen.

We’ve been duped for decades about food:

Turns out sugar isn’t benign. It’s the real poison. Fats aren’t actually bad. They are essential. Carbs aren’t terrible. They are necessary.

We’ve been lied to about plastics. Vaccines. GMOs. The list goes on.

What is the consequence?…

India readies pitch to woo global investors at Davos

India is eager to tell global investors its "growth story" when luminaries gather at the World Economic Forum in Davos next week, the South Asian country's secretary for promotion of industry and internal trade said in an interview.

Read more here

AI를 활용해 경도 인지장애 환자의 알츠하이머 치매 발병 가능성을 예측할 수 있는 예후진단 테스트 ‘브레인시(BrainSee)’가 최초로 FDA 허가를 받았습니다. 브레인시는 기억장애형 경도인지장애(aMCI) 환자를 대상으로 뇌 MRI 데이터와 인지장애 평가척도 점수를 분석해 환자의 질병이 알츠하이머로 진행될 가능성을 평가하게 됩니다.
aMCI 환자의 경우 질병진단 후 알츠하이머성 치매 등으로 질병 진행여부가 확실하지 않아 꾸준한 모니터링이 필요하지만, 고비용, 침습적 검사는 환자에게 정신적, 경제적 부담으로 작용하게 됩니다. 브레인시를 통해 경도인지장애 환자를 알츠하이머성 치매로 진행될 가능성이 높은 고위험군 또는 저위험군으로 조기에 분류하면 불필요한 검사를 감소시켜 환자들에게 큰 메리트를 제공할 것으로 기대하고 있습니다.

https://lnkd.in/gaM5PDkW